Photo from wikipedia
Daratumumab (DARA) is a human monoclonal antibody for the treatment of multiple myeloma (MM). DARA binds to CD38 on RBCs and interferes with detection of RBC alloantibodies. The objective of… Click to show full abstract
Daratumumab (DARA) is a human monoclonal antibody for the treatment of multiple myeloma (MM). DARA binds to CD38 on RBCs and interferes with detection of RBC alloantibodies. The objective of this study was to evaluate the risk of RBC alloimmunization in MM patients treated with DARA.
Keywords:
multiple myeloma;
rbc alloimmunization;
risk rbc;
patients treated
Journal Title: Vox Sanguinis
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Vox Sanguinis
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!